文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under
侵权投诉

Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under

Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under immunosuppressive therapy

whereas similar 79.6% to 101.1% in the both seroprotection groups (90%, rate was to 100.9%, vs. 97.5%, CI 94.1% 95% CI after immunisation and factor increase p=0.121). In addition, GMT in GMT were alike in the two groups (None p=0.992 and (3.7%) of the pJDM =0.827 respectively).patients and three vious healthy controls received pre-2008/2009 in uenza vaccine (immunisation with pseasonal =0.562). Immunisation response and

disease parameters in JDM patientsDemographic JDM scores, lymphopenia and treatment data, muscle enzymes, at vaccination according to presence or absence of seroconversion in JDM pa-tients after in uenza A H1N1/2009 vac-cination are shown in Table II.

Demographic in the two groups (data were comparable The tients clinical courses p>0.05) (Table II). of agents were monophasic in 3 (15.8%), under any immunosuppressive 19 JDM pa-recurrent in 7 (36.8%) and chronic in 9 (47.4%). A higher frequency of chronic course verted tients (100% compared was observed in non-serocon-of the patients had moderate or severe vs. 27%, to seroconverted p=0.012). None pa-clinical activity or muscle weakness and seroconverted groups had comparable levels of JDM and non-seroconverted scores (observed in patients that did not sero-p>0.05). Lymphopenia was not converted. Muscle enzymes were also alike in both groups, except for a high-er median level of aldolase in the non-seroconverted vsgarding therapy, the four JDM patients . 4.4 [2.1–7.2] patients IU/L, (7.4 p=0.026). [4.9–9.1] Re-that course did not seroconvert had ten (>20 under of disease higher dose and were more chronic of-seroconverted (50% mg/day) compared of prednisone Likewise, a higher frequency of metho-vs. 4%, to those p=0.039). that trexate combination of prednisone, methotrex-(100% vs. 38%, p=0.036) and ate and cyclosporine use (50% pdid not seroconvert (Table II).

=0.039) was observed in patients that vs. 4%, Further analysis of the possible effect of vaccine in disease parameters revealed that cination the median DAS (0 of [0–11] pre- and vs. 0 post-vac-[0–14],

Table I.increases in the GMT (FI in GMT) in juvenile dermatomyositis (JDM) patients and controls Seroprotection (SP), seroconversion (SC), geometric mean titers (GMT) and factor before and after in uenza A/H1N1/2009 vaccination.

Variables

JDM (n=30) Controls (n=81) p-valueSP

Before immunisation

After immunisation 30 (12.5–45.5) 22.2 0.457SC

86.7 90 (79.6–101.1) (74.9–99.3) 97.5 (13.1–31.3) 97.5 (94.1–100.9) (94.1–100.9) 0.1210.044GMT

Before immunisation

After immunisation FI in GMT

259.9 13.8 (9.1–21)

18.8

(155.5–434.4) (11.4–31.1)

260.6 13 (10.1–16.9) 0.81720 (204.4–332.2) (15.2–26.3)

0.9920.827

Values expressed in % (95% con dence interval).

Table courses and scores, lymphopenia and treatment at vaccination according to seroconversion II. Demographic data, muscle enzymes, juvenile dermatomyositis (JDM) clinical (SC) to in uenza A H1N1/2009 vaccine in JDM patients.

Variables at vaccination (reference values) SC (n=4) Without SC (n=26) With p-value

Demographic data Current age, years

Disease duration, years 0.646 Female gender

4.9 15 (12–16) (4–12) 15.5 0.806Muscle enzymes

2 (50)

7.2 (9–21) 17 (2–17) (65) 0.611 AST, IU/liter (<41) 26

ALT, IU/liter (<37)

19 (10–45) 0.471 LDH, IU/liter (240–480) 0.155 CK, IU/liter (39–308) 196 41 (10–35) (32–57) 183 31 (12–72) 0.858 Aldolase, IU/liter (<7.6) 223 (168–211) 124 (93–469) 0.647JDM clinical course 7.4 (65–533) 4.4 (49–387) (2.1–7.2) 0.026 Monophasic Recurrent 0 (4.9–9.1) 0 (0) 11 0.267 Chronic

8 (42) JDM Scores 4 (0) (100)

7 (31) (27) 0.5500.012 DAS (0–20) CMAS (0–52) 51.5 3

(0–11) 52 0 (0–7) 0.126 MMT (0–80)

80 (48–52) 80 (45–52) 0.894Lymphopenia (<1000/mm32 (74–80) (7.7) 0.621Treatment )

0 (80–80) 1.0 Prednisone

Current dose, mg

11 4 (42) 0.097 Prednisone > 20mg/day 5.8 4 (0)

(100)

0.646 Immunosuppressor (any) 2 (2.5–12.5) 15 1 (1–35) (4) 0.039 MTX

4 (50) 10 (58) 0.267 Cyclosporine

4 (100) Prednisone, MTX and cyclosporine 2 (100) 4 (38) 1 (15) 0.1690.036 Azathioprine 2 (50) 2 (4) 0.039 Chloroquine

0 (50) 3 (0) (75)

4 (8) (15)

0.169

1.0Values notransferase; LDH: lactate dehydrogenase; CK: creatine kinase; DAS: disease activity score; CMAS: expressed in median (range) or n (%), AST: aspartate aminotransferase; ALT: alanine ami-childhood myositis assessment scale; MMT: manual muscle testing; MTX: methotrexate.

p[41–52], =0.954), CMAS (52 [45–52] vs. 52 vs80] (187 [93–469] . 31 [11–63] IU/liter, largely unchanged. Likewise, no signi -vs. 80 [79–80], p=0.803) and MMT (80 [74–p=0.987) remained er, cant differences were observed in mus-[33–481] IU/liter, p=0.906), CK (124 [49–533] vs. 179 [83–446] IU/lit-p=0.825), LDH vs. 102 cle enzymes before and after immuni-se (4.8 [2.1–9.1] p=0.339) and aldola-sation: AST (20 [10–45] pvs. 4.8 [0–7.5] IU/liter, IU/liter, p=0.246), ALT vs(32.5 . 23 [11–36] [12–72] before =0.333). Frequencies of lymphopenia comparable (7% and after vsimmunisation . 0%, p=0.492). Fur-

were 586

上一页第4页

你可能喜欢

热门文档

相关文档

  • Influenza (the flu)

    Influenza (the flu)_英语学习_外语学习_教育专区。流感预防Influenza (the flu) By Salwa Hassan Teama Ain Shams University Difference Between Cold or FLU ...

  • 流感病毒与流感疫苗 - Influenza and Influenza Vaccines

    流感病毒与流感疫苗 - Influenza and Influenza Vaccines_生物学_自然科学_专业资料。流感病毒与流感疫苗 - Influenza and Influenza Vaccines...

  • Influenza

    Influenza (Flu) What Everyone Should Know About Flu and the Flu Vaccine What is the flu? The flu is a contagious respiratory illness caused by ...

  • Influenza

    Influenza Miley ClassB Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the ...

  • HOW_TO_PREVENT_INFLUENZA_en_20051028

    Influenza (flu): ? is a highly infectious viral disease caused by various types of influenza viral strains ? Seasonal Influenza In Hong Kong, the ...

  • Influenza

    42页 免费 Influenza 32页 10财富值搜你所想,读你所爱 拒绝盗版,营造绿色文库 如要投诉违规内容,请到百度文库投诉中心;如要提出功能问题或意见建议,请点击...

  • Influenza

    www.themegallery.com Spring - prone diseases Epidemic cerebrospinal meningitis、 、 influenza , mumps and other respiratory diseases流脑、流感、流腮等呼吸道...

  • INFLUENZA-禽流感 - 关于流感

    Summer 2008 Workshop in Biology and Multimedia for High School Teachers INFLUENZA VIRUS: A Model for Learning About Disease Laurie St.Pierre Sandwich High...

  • 分子病毒学1 influenza_virus

    流行性感冒病毒 influenza virus 流行性感冒病毒(influenza virus)简称流感 病毒。按病毒核蛋白(nucleocapside protein,NP) 和基质蛋白(matrix protein, M)分成甲(A)...

  • influenza

    流行性感冒 influenza 定义:流行性感冒简称流感,是 由流行性感冒病毒引起的急性呼 吸道传染病。 特征:病毒极易变异; 传染性强; 全身症状重; 呼吸道症状轻。 ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email